Diasome Pharmaceuticals, Inc. — Form D

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-17. The offering totals $8.0M, of which $4.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Richard Blair CarusoDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Devang KantesariaDirectorMiami, FL
Marc PennDirectorCleveland, OH
Peter Blair TollmanDirectorCleveland, OH
Robert GehoDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
Robert GehoPromoterCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Thomas McDonaldDirectorMiami, FL
Marc Blair PennDirectorCleveland, OH
Frank McCaneyDirectorPhiladelphia, PA
W. Blair GehoDirectorCleveland, OH
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-15D$15.6M$3.1M
2023-06-30D$15.0M$9.0M
2022-09-08D$19.1M$16.7M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2018-10-26D$18.6M$12.1M
2009-04-13D/A$13.4M$12.9M

More